AR072525A1 - Tratamiento de artritis reumatoidea con beta defensinas de mamiferos. uso. metodo. - Google Patents
Tratamiento de artritis reumatoidea con beta defensinas de mamiferos. uso. metodo.Info
- Publication number
- AR072525A1 AR072525A1 ARP090102742A ARP090102742A AR072525A1 AR 072525 A1 AR072525 A1 AR 072525A1 AR P090102742 A ARP090102742 A AR P090102742A AR P090102742 A ARP090102742 A AR P090102742A AR 072525 A1 AR072525 A1 AR 072525A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- rheumatoid arthritis
- mammals
- beta defensins
- beta defensin
- Prior art date
Links
- 108050002883 beta-defensin Proteins 0.000 title abstract 4
- 102000012265 beta-defensin Human genes 0.000 title abstract 4
- 206010039073 rheumatoid arthritis Diseases 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 title 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
- 101000884714 Homo sapiens Beta-defensin 4A Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 102000049262 human DEFB4A Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Marine Sciences & Fisheries (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08160761 | 2008-07-18 | ||
| EP09160448 | 2009-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR072525A1 true AR072525A1 (es) | 2010-09-01 |
Family
ID=41530821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090102742A AR072525A1 (es) | 2008-07-18 | 2009-07-17 | Tratamiento de artritis reumatoidea con beta defensinas de mamiferos. uso. metodo. |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8232248B2 (enExample) |
| EP (1) | EP2320928B1 (enExample) |
| JP (1) | JP2011528334A (enExample) |
| KR (1) | KR20110031970A (enExample) |
| CN (1) | CN102159234A (enExample) |
| AP (1) | AP2011005536A0 (enExample) |
| AR (1) | AR072525A1 (enExample) |
| AU (1) | AU2009272683A1 (enExample) |
| BR (1) | BRPI0915778A2 (enExample) |
| CA (1) | CA2730666A1 (enExample) |
| EA (1) | EA201170220A1 (enExample) |
| IL (1) | IL210716A0 (enExample) |
| MX (1) | MX2011000567A (enExample) |
| NZ (1) | NZ590469A (enExample) |
| TW (1) | TW201004639A (enExample) |
| WO (1) | WO2010007168A2 (enExample) |
| ZA (1) | ZA201100460B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102159233A (zh) | 2008-07-18 | 2011-08-17 | 诺维信阿德宁生物技术公司 | 使用哺乳动物β防御素的炎性肠病的治疗 |
| MX2011000569A (es) * | 2008-07-18 | 2011-02-23 | Novozymes Adenium Biotech As | Tratamiento de enfermedades inflamatorias con beta-defensinas de mamifero. |
| KR101320472B1 (ko) * | 2010-06-16 | 2013-10-23 | 주식회사 나이벡 | 항균 또는 항염증 활성을 가지는 펩타이드 및 이를 유효성분으로 함유하는 약제학적 조성물 |
| EP2696680B1 (en) | 2011-04-15 | 2018-11-28 | Marine Polymer Technologies, Inc. | Treatment of hsv infections with poly-n-acetyl glucosamine nanofibers |
| JP6219277B2 (ja) | 2011-07-08 | 2017-10-25 | ディフェンシン セラピューティクス アンパルトセルスカブＤｅｆｅｎｓｉｎ Ｔｈｅｒａｐｅｕｔｉｃｓ Ａｐｓ | 炎症性腸疾患の経口治療 |
| WO2013026794A1 (en) | 2011-08-19 | 2013-02-28 | Novozymes | Novel immunomodulatory peptide |
| KR102631542B1 (ko) * | 2018-03-14 | 2024-02-01 | 서울대학교산학협력단 | 염증 감소능 및 줄기세포로부터 연골세포로의 분화 촉진능을 가지는 이중 기능성 펩타이드 및 이의 용도 |
| KR102244161B1 (ko) * | 2018-08-31 | 2021-04-26 | 주식회사 나이벡 | 다중의 질환 바이오마커의 기능 및 발현을 억제하는 펩타이드의 신규한 용도 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080194481A1 (en) * | 2001-12-21 | 2008-08-14 | Human Genome Sciences, Inc. | Albumin Fusion Proteins |
| US20060115480A1 (en) * | 2002-12-19 | 2006-06-01 | Yitzchak Hillman | Disease treatment via antimicrobial peptide inhibitors |
| GB0514482D0 (en) | 2005-07-14 | 2005-08-17 | Ares Trading Sa | Protein |
| WO2007081486A2 (en) | 2005-12-15 | 2007-07-19 | Ventria Bioscience | Oral administration of defensins to treat intestinal diseases |
| WO2007087557A2 (en) | 2006-01-24 | 2007-08-02 | University Of Maryland Biotechnology Institute | Surface-layer protein coated microspheres and uses thereof |
| WO2009046833A1 (en) * | 2007-09-11 | 2009-04-16 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| CN102159233A (zh) * | 2008-07-18 | 2011-08-17 | 诺维信阿德宁生物技术公司 | 使用哺乳动物β防御素的炎性肠病的治疗 |
| MX2011000569A (es) * | 2008-07-18 | 2011-02-23 | Novozymes Adenium Biotech As | Tratamiento de enfermedades inflamatorias con beta-defensinas de mamifero. |
-
2009
- 2009-07-17 MX MX2011000567A patent/MX2011000567A/es not_active Application Discontinuation
- 2009-07-17 AU AU2009272683A patent/AU2009272683A1/en not_active Abandoned
- 2009-07-17 AP AP2011005536A patent/AP2011005536A0/xx unknown
- 2009-07-17 EP EP09780793A patent/EP2320928B1/en active Active
- 2009-07-17 EA EA201170220A patent/EA201170220A1/ru unknown
- 2009-07-17 US US12/504,920 patent/US8232248B2/en not_active Expired - Fee Related
- 2009-07-17 BR BRPI0915778A patent/BRPI0915778A2/pt not_active IP Right Cessation
- 2009-07-17 AR ARP090102742A patent/AR072525A1/es not_active Application Discontinuation
- 2009-07-17 WO PCT/EP2009/059255 patent/WO2010007168A2/en not_active Ceased
- 2009-07-17 KR KR1020117002949A patent/KR20110031970A/ko not_active Withdrawn
- 2009-07-17 CA CA2730666A patent/CA2730666A1/en not_active Abandoned
- 2009-07-17 NZ NZ590469A patent/NZ590469A/xx not_active IP Right Cessation
- 2009-07-17 JP JP2011517956A patent/JP2011528334A/ja active Pending
- 2009-07-17 CN CN200980136396XA patent/CN102159234A/zh active Pending
- 2009-07-20 TW TW098124400A patent/TW201004639A/zh unknown
-
2011
- 2011-01-18 ZA ZA2011/00460A patent/ZA201100460B/en unknown
- 2011-01-18 IL IL210716A patent/IL210716A0/en unknown
-
2012
- 2012-07-09 US US13/544,237 patent/US20120309686A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011528334A (ja) | 2011-11-17 |
| WO2010007168A3 (en) | 2010-06-17 |
| AP2011005536A0 (en) | 2011-02-28 |
| CN102159234A (zh) | 2011-08-17 |
| IL210716A0 (en) | 2011-03-31 |
| BRPI0915778A2 (pt) | 2019-09-24 |
| NZ590469A (en) | 2012-08-31 |
| US8232248B2 (en) | 2012-07-31 |
| ZA201100460B (en) | 2012-09-26 |
| CA2730666A1 (en) | 2010-01-21 |
| US20120309686A1 (en) | 2012-12-06 |
| KR20110031970A (ko) | 2011-03-29 |
| WO2010007168A2 (en) | 2010-01-21 |
| EP2320928A2 (en) | 2011-05-18 |
| EA201170220A1 (ru) | 2011-08-30 |
| AU2009272683A1 (en) | 2010-01-21 |
| EP2320928B1 (en) | 2012-11-07 |
| US20100016231A1 (en) | 2010-01-21 |
| TW201004639A (en) | 2010-02-01 |
| MX2011000567A (es) | 2011-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6491059A2 (es) | Diferenciacion de las celulas madre mesenquimales | |
| AR072032A1 (es) | Tratamiento de enfermedades inflamatorias del intestino con beta defensinas de mamiferos | |
| AR087973A1 (es) | Variantes del factor 21 del crecimiento de fibroblastos | |
| ES2689512T3 (es) | Receptores de células T que reconocen MAGE restringido por HLA-A1 o a HLA-Cw7 | |
| BR112012018951B8 (pt) | anticorpo monoclonal, composição farmacêutica, combinação farmacêutica, uso de um anticorpo, uso de uma composição farmacêutica e uso de uma combinação farmacêutica | |
| GT201300131A (es) | Metodos de tratamiento de trastornos asociados con el fgf21 | |
| BR112013032717A2 (pt) | coagonistas do receptor de glucagon/glp-1 | |
| DOP2017000128A (es) | Nuevas normalizaciones y dispositivos médicos para la preparación de plasma rico en plaquetas (prp) o concentrado de médula ósea (bmc) solos o combinados con ácido hialurónico | |
| MX366906B (es) | Purificacion de iduronato-2-sulfatasa. | |
| ES2721309T3 (es) | Composición para preparar tagatosa y método para preparar tagatosa a partir de fructosa | |
| ES2572215T3 (es) | Anticuerpo neutralizante contra el receptor de prolactina Mat3 y su uso terapéutico | |
| MX380772B (es) | 3-epimerasa. | |
| PE20141727A1 (es) | Composiciones, usos y metodos para tratamiento de trastornos y enfermedades metabolicas | |
| CL2007001335A1 (es) | Anticuerpo anti cd40; acido nucleico que lo codifica; celula; cultivo celular; metodo de produccion; composicion farmaceutica; metodo para seleccionar un anticuerpo anti cd40; y su uso para tratar sintomas de un trastorno autoinmune y/o un trastorno inflamatorio y/o para reducir el rechazo al injerto y/o para el tratamiento de cancer positivos a cd40. | |
| NI201200134A (es) | Polipéptidos agonistas que se enlazan a dr5 | |
| MX347600B (es) | Uso de una composicion que comprende un peptido antimicrobiano como un conservador de alimentos. | |
| BR112013031084A2 (pt) | meios e métodos para imunoterapia celular ativa de câncer usando células tumorais mortas por alta pressão hidrostática e células dendríticas | |
| AR083126A1 (es) | Composicion vacunal para el control de las infestaciones por ectoparasitos | |
| ECSP15031046A (es) | Polipéptidos estabilizados del factor de crecimiento tipo insulina | |
| BR112014002173A2 (pt) | proteínas purificadas | |
| AR095076A1 (es) | Péptidos y composiciones para el tratamiento de daño articular | |
| PH12015502100A1 (en) | Reducing the risk of autoimmune disease | |
| NZ590469A (en) | Treatment of rheumatoid arthritis with human beta defensins (1-4) | |
| EA201590601A1 (ru) | Применение pedf-производных полипептидов для лечения остеоартрита | |
| PE20141826A1 (es) | Uso de composiciones nutricionales que incluyen lactoferrina en apoyo a la resistencia a enfermedades y condiciones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |